RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/A4QlLxOJyb #accfit
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
nothing new on the aspirin in primary prevention front it seems!
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
RT @TKDsosyal: The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and…
The role of ASA in primary prevention: 15 RCT’s including >160k subjects • No reduction in all-cause mortality, CV death and non-CV death • ⬇️ risk of non-fatal MI, TIA, ischemic stroke • ⬆️ risk of non-fatal bleeding @JACCJournals https://t.co/CSMGds2
RT @thecooler9: #Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Tota…
#Aspirin for #primaryprevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events. Total cancer & non-cancer death were similar @JACCJournals https://t.co/pRybUp51wd @krychtiukmd @MihaiTrofenciuc @proftomquinn @cpga
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/apqvMuNxxM
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @caldera_99: Nice article about Aspirin in Primary prevention. https://t.co/h1iv0vDoap
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @AguilarMolina_: Premium nocere! https://t.co/dmxpE0Cf4o
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @jimjimpau: The risks and benefits of aspirin for primary prevention. Great article and illustration from @JACCJournals. "Aspirin for p…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @caldera_99: Nice article about Aspirin in Primary prevention. https://t.co/h1iv0vDoap
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @caldera_99: Nice article about Aspirin in Primary prevention. https://t.co/h1iv0vDoap
RT @FormigaFrancesc: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/s5SvYUNUVW
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
Nice article about Aspirin in Primary prevention.
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/t8HaXFfyEt @ClubVasculaire @AJeunesMedVasc @BozonGuillaume @faresmoust @GMahe_ @LaurentBertole1 @AtulPathak31 @alebura @FZores https://t.co/BSKJa7GMEU
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @MichaelMegalyMD: Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events @MarwanSaadMD Thank you for all your mentorship @JDawnAbbott1 @DLBHATTMD @herbaronowMD https://t.co/FvXcxCAnPX @MHIF_Heart #ACCFIT #cardiot
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
The risks and benefits of aspirin for primary prevention. Great article and illustration from @JACCJournals. "Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events." https://t.co/dyOJsaBioy
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @MarwanSaadMD: Thank you for your mentorship! @DLBHATTMD @JDawnAbbott1 @herbaronowMD https://t.co/LnAKwhwnW3
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
excelente!
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
🤷🏻♀️
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @DLBHATTMD: Aspirin for Primary Prevention of Cardiovascular Events https://t.co/ZwdMMSyG2k
Aspirin for Primary Prevention of Cardiovascular Events https://t.co/t8mYqA4rwn
Premium nocere!
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
Thank you for your mentorship! @DLBHATTMD @JDawnAbbott1 @herbaronowMD
RT @gonzaeperez: ASPIRINA EN PREVENCION PRIMARIA Metanálisis 15 trials, >165.000 pts sin enf CV. ⬇️ eventos CV y ⬆️ eventos hemorrágicos S…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…
RT @novitskiynic: Once again, the benefits or harm ⚖️ of #Aspirin in primary #prevention? 📌Analysis of 15 RCT, 165,502 participants (aspir…